Rhabdomyolysis secondary to interaction of statins with macrolides in renal transplant patients [2];Rabdomiolisis secundaria a interacción de estatinas con macrólidos en un paciente con trasplante renal

Nefrologia

Volumn 24, Issue 4, 2004, Pages 382-383

  Valero, R ^a   Rodrigo, E ^a,b   Zubimendi, J A ^a   Arias, M ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b Serv Nefrol   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; SIMVASTATIN;

AGED; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; GRAFT INFECTION; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; LETTER; RHABDOMYOLYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; ANTICHOLESTEREMIC AGENTS; CLARITHROMYCIN; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HUMANS; HYPERLIPIDEMIAS; KIDNEY TRANSPLANTATION; MALE; METABOLIC DETOXICATION, DRUG; POSTOPERATIVE COMPLICATIONS; RESPIRATORY TRACT INFECTIONS; RHABDOMYOLYSIS; SIMVASTATIN;

EID: 4544383611     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Lee AJ, Maddix: Rhabdomyiolisis secondary to a drug interaction between simvastatin and clarithromycin. Ann Pharmacother 35(1): 26-31, 2001.
2. Williams D, Feely J: Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet 41(5); 343-70, 2002.
3. Vlahakos DV, Manginas A, Chilidou D, Zamanika C, Alivizatos PA: Itraconazole-induced rhabdomyolisis and acute renal failure in a heart transplant recipient treated with simvastatin and cyclosporine. Transplantation 27; 73(12): 1962-4, 2002.
4. Amsden GW, Kuye O, Wei GC: A study of the interaction potential of azithromycin and clarithromycin with atorvastatin in healthy volunteers. J Clin Pharmacol 42(4): 444-9, 2002.
5. Martin J, Krum H: Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant? Drug Saf 26(1): 13-21, 2003.